Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

CXCL10 Triggers Early Microglial Activation in the Cuprizone Model.
Environmental factors related to multiple sclerosis in Indian population.
The effectiveness of percutaneous balloon compression in the treatment of trigeminal neuralgia in patients with multiple sclerosis.
A combined post-mortem magnetic resonance imaging and quantitative histological study of multiple sclerosis pathology.
[Differential diagnosis of optic neuritis (review].
The magnetic resonance imaging appearance of monophasic acute disseminated encephalomyelitis: an update post application of the 2007 consensus criteria.
Circulating MicroRNAs: A Novel Class of Potential Biomarkers for Diagnosing and Prognosing Central Nervous System Diseases.
Upregulation of immunoglobulin-related genes in cortical sections from multiple sclerosis patients.
A randomized clinical trial of oral versus intravenous methylprednisolone for relapse of MS.
Pathophysiology, assessment and management of multiple sclerosis spasticity: an update.
Multiple sclerosis: Disease activity is reduced in CIS after BCG vaccination.
Aquaporin-4 antibody-positive cases beyond current diagnostic criteria for NMO spectrum disorders.
Improving multiple sclerosis care: an analysis of the necessity for medication therapy management services among the patient population.
[Oculomotor system and multiple sclerosis.]
Whole-body in vivo monitoring of inflammatory diseases exploiting human interleukin 6-luciferase transgenic mice.
Abnormal distribution of AQP5 in labial salivary glands is associated with poor saliva secretion in patients with Sjögren's syndrome including neuromyelitis optica complicated patients.
Perspectives on cytokine-directed therapies in multiple sclerosis.
Corneal confocal microscopy in chronic inflammatory demyelinating polyneuropathy.
In vivo imaging reveals rapid astrocyte depletion and axon damage in a model of neuromyelitis optica-related pathology.
Cost Effectiveness Analysis of Avonex and CinnoVex in Relapsing Remitting MS.
Defective structural RNA processing in relapsing-remitting multiple sclerosis.
Patient expression of emotions and neurologist responses in first multiple sclerosis consultations.
Chitinase 3-like 1: prognostic biomarker in clinically isolated syndromes.
Correction: Imatinib Ameliorates Neuroinflammation in a Rat Model of Multiple Sclerosis by Enhancing Blood-Brain Barrier Integrity and by Modulating the Peripheral Immune Response.
A pilot, longitudinal, 24-week study to evaluate the effect of interferon beta-1a subcutaneous on changes in susceptibility-weighted imaging-filtered phase assessment of lesions and subcortical deep-gray matter in relapsing-remitting multiple sclerosis.

Pages